Rrraum / Shutterstock.com
Jazz Pharmaceuticals, based in Ireland, will buy US company Celator Pharmaceuticals for $1.5 billion in cash.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at email@example.com
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Jazz Pharmaceuticals, Celator Pharmaceuticals, AML, oncology, mergers and acquisitions, Vyxeos